Se connecter Inscription gratuite

NeuroVive Pharmaceutical AB Marge opérationnelle

Quel est le Marge opérationnelle de NeuroVive Pharmaceutical AB?

Le Marge opérationnelle de NeuroVive Pharmaceutical AB est -126,430.38%

Quelle est la définition de Marge opérationnelle?



La marge opérationnelle est le ratio du résultat opérationnel divisé par les ventes nettes et présenté en pourcentage.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Marge opérationnelle des entreprises dans Health Care secteur sur OTC par rapport à NeuroVive Pharmaceutical AB

Que fait NeuroVive Pharmaceutical AB?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Entreprises avec marge opérationnelle similaire à NeuroVive Pharmaceutical AB